Department of Translational Medical Bioengineering (TMB), FBMI

The department of translation medical bioengineering was founded in 2018. The direction of the department is the engineering and technological foundations of translation medicine – the modern branch, which ensures the prompt implementation (translation) of fundamental discoveries in the field of natural sciences to the health care practice.

Regenerative medicine deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function based on tissue engineering and molecular biology methods.

Biopharmaceutical engineering is an interdisciplinary science and technology branch, aimed at the development and production of therapeutic, prophylactic and diagnostic products (preparations) of biological origin (vaccines, blood and its components, allergens, gene therapeutic structures, tissues, recombinant proteins, living cells for cell therapy, etc.)

The department teaches bachelors and masters, as well as doctors of philosophy in specialty “Biomedical engineering” (specialization: “Regenerative and biopharmaceutical engineering”).

Highly qualified staff, including 6 faculty members (one professor, three associate professors, a senior lecturer and an assistant), provides the training process and scientific developments.